/NOT FOR DISSEMINATION IN THE US OR THROUGH US NEWSWIRE SERVICES/

VANCOUVER, BC, June 28, 2022 /CNW/ – Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) (“Sproutly” or the “Company“) announces that the Company has entered into a sixth supplemental indenture dated June 24, 2022 (the “Sixth Supplemental Indenture“) between the Company and TSX Trust Company, as trustee, which amends the terms of its convertible debenture indenture dated October 24, 2018 (the “Original Indenture“), as amended by the first supplemental indenture dated April 24, 2020 (the “First Supplemental Indenture“), as further amended by the second supplemental indenture dated July 23, 2020 (the “Second Supplemental Indenture“), as further amended by the third supplemental indenture dated September 23, 2020 (the “Third Supplemental Indenture“), as further amended by the fourth supplemental indenture dated April 22, 2021 (the “Fourth Supplemental Indenture“), and as further amended by the fifth supplemental indenture dated April 25, 2022 (the “Fifth Supplemental Indenture“, together with the Original Indenture, the First Supplemental Indenture, the Second Supplemental Indenture, the Third Supplemental Indenture, and the Fourth Supplemental Indenture, the “Indenture“) providing for the issuance of 8.0% senior unsecured convertible debentures in the aggregate principal amount of $10,750,000 (the “Debentures“).

Pursuant to the Sixth Supplemental Indenture, the Indenture was modified to extend the maturity date by one month, subject to the prior written approval of Debenture holders holding more than 66 2/3% of the principal amount of all of the outstanding Debentures.

As of the date hereof, Debentures in the principal amount of $1,750,000 are currently outstanding and due to mature on June 24, 2022. The Debentures were originally convertible by the holders thereof into common shares of the Company at a price of $0.75 per common share. Pursuant to the First Supplemental Indenture, the Company and the Debenture holders approved an amendment to the conversion price to $0.105 per share. Pursuant to the Second Supplemental Indenture, the Indenture was amended to provide for certain payments of principal and interest under the Indenture to be settled by the Company in cash or common shares of the Company. Pursuant to the Third Supplemental Indenture, the Indenture was amended to move the conversion price to $0.06 per share and to extend the maturity date by six months to April 24, 2021. Pursuant to the Fourth Supplemental Indenture, the Indenture was amended to extend the maturity date by a year to April 24, 2022. Pursuant to the Fifth Supplemental Indenture, the Indenture was amended to extend the maturity date by two months to June 24, 2022.

In connection with the execution of the Sixth Supplemental Indenture, the Company has extended the maturity date from June 24, 2022 to July 24, 2022.

For additional details regarding the Debentures, please refer to the Company’s news releases dated October 24, 2018, December 21, 2018, April 24, 2020, July 30, 2020, September 23, 2020, April 22, 2021, and April 25, 2022 along with the Company’s final short form prospectus dated December 19, 2018, each of which are available on the Company’s SEDAR profile at www.sedar.com.

About Sproutly Canada, Inc.

Sproutly is the exclusive licensee of APP technology (www.infusionbiosciences.com) to produce proprietary natural water-soluble Infuz2O and BioNatural Oils. Beverage and edible products produced using the whole plant extracts will deliver true to strain whole plant experiences to new consumers and cannabis connoisseurs alike, ushering in the Cannabis 3.0 revolution. Sproutly intends to enter into partnerships with established companies and consumer brands to market unique products that deliver cannabis and hemp whole plant experience and health and wellness benefits, in major commercial territories around the world.

SOURCE Sproutly Canada Inc.

For further information: Please visit: www.sproutly.ca; Contact: Dr. Arup Sen, Chief Executive Officer and Director of Sproutly Canada, Inc., Email: investors@sproutly.ca

VANCOUVER, BC, June 27, 2022 /CNW/ – Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) (“Sproutly” or the “Company“), announced today that Toronto Herbal Remedies Inc. (“THR”) and Sproutly’s subsidiary, that holds the shares of THR, Sproutly Inc. (together the “Filers”), filed a petition with the Ontario Superior Court of Justice for protection under the Companies’ Creditors Arrangement Act (“CCAA“) in order to restructure their business and financial affairs.  The Company and its other subsidiaries are not parties to the CCAA filing and will now focus solely on the commercialization of its APP technology.

After going through a time and resource consuming process to sell THR and the facility, careful consideration of available alternatives and consultation with legal and financial advisors, the directors of the Company decided that in the interest of the Company’s shareholders, THR’s divestiture should be carried out by a court appointed monitor under a CCAA filing.

The Initial Order includes, among other things: (i) a stay of proceedings in favour of the Filers; (ii) approval of a DIP (Debtor in Possession) Loan (as described below); and (iii) the appointment of BDO Canada Limited as monitor of the Filers (in such capacity, the “Monitor“).  The Filers are seeking creditor protection under the CCAA in order to receive a stay of proceedings that will allow the Monitor to conduct a sale and investment solicitation process (“SISP“) and facilitate a transaction.

Under the Initial Order, the Filers will operate in the ordinary course throughout the CCAA proceedings during the SISP. Management of the Filers will remain responsible for the day-to-day operations of the Filers, under the general  oversight of the Monitor.  The Filers’ day-to-day obligations to employees and key suppliers of goods and services, from and after the filing date, will  be met using the DIP Loan.

In order to fund the CCAA proceedings, the SISP and other short term working capital requirements, the Filers have executed a term sheet with 0982244 BC Ltd. o/a Isle of Mann Property Group., on behalf of its clients (the “DIP Lender“), pursuant to which the DIP Lender will advance a debtor-in-possession loan in the amount of $750,000 (the “DIP Loan“). The DIP Loan is conditional on, among other things, the issuance of the Initial Order which has been granted.

The Company is not part of the CCAA proceedings.  The Company is the holder of the APP technology license from Infusion Biosciences for Canada, the EU, the UK, Australia, Israel and Jamaica.  The Company is transitioning from operating a licensed cannabis facility to a cannabis technology company, as evidenced by the plan for the Filers.  The Company will continue to partner with licensed producers to produce products utilizing the APP technology, which is capable of producing strain specific cannabis extracts, edible and beverage products.  The Company has one partnership agreement in place whereby the Company will produce its own branded products while actively pursuing further sublicensing and other such arrangements. 

“At this stage of Sproutly’s evolution, our best path to capitalize on the APP technology and be able to produce innovative products required the sale of THR.” said Dr. Arup Sen, Sproutly’s CEO. “Especially in light of our progress in the newly formed joint venture with KCI, the execution of product development, manufacturing, and marketing in Canada requires a total focus on the operations of the joint venture and approaching prospective partners in the territories where Sproutly has rights to APP technology.” he added.About Sproutly Canada, Inc.

Sproutly is positioning to become a leading supplier of proprietary cannabis ingredients, brands, and customized formulations for the cannabis beverage and edibles marketplaces in Canada, Europe, Australia, and other international markets. Our proprietary natural water-soluble Infuz2O and BioNatural Oils are designed to deliver true to strain whole plant experiences to new consumers and cannabis connoisseurs alike, ushering in the Cannabis 3.0 revolution. Sproutly will enter into partnerships with globally established consumer brands to leverage their existing customer bases, brand recognition, distribution networks to deliver this scientific breakthrough with speed and efficiency in major commercial territories around the world.

For more information on Sproutly, please visit: www.sproutly.ca.Forward-Looking Statements

Cautionary Note Regarding Forward-Looking Statements: This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws or forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements relate to future events or future performance and reflect the expectations or believes regarding future events of management of Sproutly. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or “occur”. This information and these statements, referred to herein as “forward‐looking statements”, are not historical facts, are made as of the date of this news release and include without limitation, statements regarding discussions of future plans, estimates and forecasts and statements as to management’s expectations and intentions.

These forward‐looking statements involve numerous risks and uncertainties and actual results might differ materially from results suggested in any forward-looking statements. These assumptions, risks and uncertainties include, among other things, the Company’s inability to launch or supply its Cannabis 2.0 products in Canada; the Company’s inability to complete agreements with partners and launch additional products; potential negative consumer, investor or public perception of the additional product lines; changes in consumer preferences and product trends; and political, legal and regulatory uncertainty relating to cannabis products generally. In making the forward looking statements in this news release, the Company has applied several material assumptions, including without limitation, that the Company will launch its Cannabis 2.0 products in Canada; that the Company’s products will be positively received by consumers in Canada; and that the Company will continue to develop and launch its Cannabis 2.0 products. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial outlook that are incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbor.

SOURCE Sproutly Canada Inc.

For further information: Dr. Arup Sen, Chief Executive Officer and Director of Sproutly Canada, Inc., Email: investors@sproutly.ca

/NOT FOR DISSEMINATION IN THE US OR THROUGH US NEWSWIRE SERVICES/

VANCOUVER, BC, April 25, 2022 /CNW/ – Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) (“Sproutly” or the “Company“) announces that the Company has entered into a fifth supplemental indenture dated April 25, 2022 (the “Fifth Supplemental Indenture“) between the Company and TSX Trust Company, as trustee, which amends the terms of its convertible debenture indenture dated October 24, 2018 (the “Original Indenture“), as amended by the first supplemental indenture dated April 24, 2020 (the “First Supplemental Indenture“), as further amended by the second supplemental indenture dated July 23, 2020 (the “Second Supplemental Indenture“), as further amended by the third supplemental indenture dated September 23, 2020 (the “Third Supplemental Indenture“), and as further amended by the fourth supplemental indenture dated April 22, 2021 (the “Fourth Supplemental Indenture“, together with the Original Indenture, the First Supplemental Indenture, the Second Supplemental Indenture, and the Third Supplemental Indenture, the “Indenture“) providing for the issuance of 8.0% senior unsecured convertible debentures in the aggregate principal amount of $10,750,000 (the “Debentures“).

Pursuant to the Fifth Supplemental Indenture, the Indenture was modified to extend the maturity date by two months, subject to the prior written approval of Debenture holders holding more than 66 2/3% of the principal amount of all of the outstanding Debentures.

As of the date hereof, Debentures in the principal amount of $1,750,000 are currently outstanding and due to mature on April 24, 2022.  The Debentures were originally convertible by the holders thereof into common shares of the Company at a price of $0.75 per common share.  Pursuant to the First Supplement Indenture, the Company and the Debenture holders approved an amendment to the conversion price to $0.105 per share.  Pursuant to the Second Supplemental Indenture, the Indenture was amended to provide for certain payments of principal and interest under the Indenture to be settled by the Company in cash or common shares of the Company.  Pursuant to the Third Supplemental Indenture, the Indenture was amended to move the conversion price to $0.06 per share and to extend the maturity date by six months to April 24, 2021.  Pursuant to the Fourth Supplemental Indenture, the Indenture was amended to extend the maturity date by a year to April 24, 2022.

In connection with the execution of the Fifth Supplemental Indenture, the Company has extended the maturity date from April 24, 2022 to June 24, 2022.

For additional details regarding the Debentures, please refer to the Company’s news releases dated October 24, 2018, December 21, 2018, April 24, 2020, July 30, 2020, September 23, 2020, and April 22, 2021, along with the Company’s final short form prospectus dated December 19, 2018, each of which are available on the Company’s SEDAR profile at www.sedar.com.

About Sproutly Canada, Inc.

Sproutly is the exclusive licensee of APP technology (www.infusionbiosciences.com) to produce proprietary natural water-soluble Infuz2O and BioNatural Oils. Beverage and edible products produced using the whole plant extracts will deliver true to strain whole plant experiences to new consumers and cannabis connoisseurs alike, ushering in the Cannabis 3.0 revolution. Sproutly intends to enter into partnerships with established companies and consumer brands to market unique products that deliver cannabis and hemp whole plant experience and health and wellness benefits, in major commercial territories around the world.

For more information on Sproutly, please visit: www.sproutly.ca.

SOURCE Stone Ridge Exploration 

For further information: Dr. Arup Sen, Chief Executive Officer and Director of Sproutly Canada, Inc.; Email: investors@sproutly.ca

/NOT FOR DISSEMINATION IN THE US OR THROUGH US NEWSWIRE SERVICES/

VANCOUVER, BC, April 18, 2022 /CNW/ – Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) (“Sproutly” or the “Company“), announces that it is expanding its commercial relationship with Kingston Cannabis Inc. (“KCI”), a Health Canada Licensed processor.

Sproutly and KCI have agreed to form a  joint venture (“JV”) that will utilize the proprietary APP technology to produce proprietary, natural, whole plant extracts of cannabis and hemp which will be used to formulate, evaluate, manufacture, and sell beverage and edible products. Sproutly will grant the JV a license to use the APP technology to produce and sell the products in Canada and Australia, and may elect to expand to other countries in which Sproutly has exclusive rights to the APP technology. KCI will provide the licensed facility and operating services to the JV while Sproutly will provide the APP license, technical services and oversight. The parties will utilize the JV to jointly develop brands, market products, and share in JV profits.  Sproutly retains the rights to grant APP licenses to other licensed producers and KCI retains the right to produce and sell other products that do not use the APP technology. APP processing operations are being set up at KCI allowing the JV to produce the extracts and finished products at the same site in order to minimize the cost to produce.

“Expanding the scope of the existing Sproutly-KCI relationship with this JV is a show of our successful collaboration in formulating and evaluating beverages using APP extracts. The JV will now integrate APP processing and finished product manufacturing to avoid potential issues that arise from divided manufacturing and avoid duplication of some operational expenses”, said Arup Sen, CEO and director of Sproutly. “We can now offer prospective partners a fully integrated flower-to-finished product service.” he added.

“We are harmonizing our operations to move in stride and release next generation botanical products and packaging that will shape medicine and technology. Our combined work, detailed research, and significant experience will be critical to establishing growth within local cannabis markets as well as international medical avenues. We are excited to welcome these new ideas to fruition and materialize a successful future with our partners.” Said Jonathan Pilon, President of KCI.

About Sproutly Canada, Inc.

Sproutly is the exclusive licensee of APP technology (www.infusionbiosciences.com) to produce proprietary natural water-soluble Infuz2O and BioNatural Oils. Beverage and edible products produced using the whole plant extracts will deliver true to strain whole plant experiences to new consumers and cannabis connoisseurs alike, ushering in the Cannabis 3.0 revolution. Sproutly intends to enter into partnerships with established companies and consumer brands to market unique products that deliver cannabis and hemp whole plant experience and health and wellness benefits, in major commercial territories around the world.

For more information on Sproutly, please visit: www.sproutly.ca.

About Kingston Cannabis Inc. 

Kingston Cannabis Inc. operates a licensed cannabis processing facility that creates high end cannabis-infused beverages, edibles, and capsules featuring recyclable metal containers.  KCI harnesses the significant experience of its co-founder in the cannabis and homeopathic markets, as well as the expertise of its partnerinproducing unique, eco-friendly, world-leading aluminum packaging. KCI has significant international connections to world cannabis markets and works with all aspects of cannabis processing from ginetics to advanced manufacturing.

For more information on KCI, please visit: www.kingstoncannabisinc.ca

Forward-Looking Statements 

Cautionary Note Regarding Forward-Looking Statements: This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws or forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements relate to future events or future performance and reflect the expectations or believes regarding future events of management of Sproutly. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or “occur”. This information and these statements, referred to herein as “forward‐looking statements”, are not historical facts, are made as of the date of this news release and include without limitation, statements regarding discussions of future plans, estimates and forecasts and statements as to management’s expectations and intentions with respect to, among other things, timing relating to the Company’s ability to complete a definitive agreement with KCI and launch Cannabis 2.0 products.

These forward‐looking statements involve numerous risks and uncertainties and actual results might differ materially from results suggested in any forward-looking statements. These assumptions, risks and uncertainties include, among other things, the Company’s inability to launch or supply its Cannabis 2.0 products in Canada; the Company’s inability to complete a definitive agreement with KCI and launch additional products; potential negative consumer, investor or public perception of the additional product lines; changes in consumer preferences and product trends; and political, legal and regulatory uncertainty relating to cannabis products generally. In making the forward looking statements in this news release, the Company has applied several material assumptions, including without limitation, that the Company will launch its Cannabis 2.0 products in Canada; that the Company’s products will be positively received by consumers in Canada; and that the Company will continue to develop and launch its Cannabis 2.0 products. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial outlook that are incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbor.

SOURCE Stone Ridge Exploration 

For further information: Dr. Arup Sen, Chief Executive Officer and Director of Sproutly Canada, Inc., Email: investors@sproutly.ca

/NOT FOR DISSEMINATION IN THE US OR THROUGH US NEWSWIRE SERVICES/

VANCOUVER, BC, April 13, 2022 /CNW/ – Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) (“Sproutly” or the “Company“), is pleased to announce that the company’s wholly-owned subsidiary, Toronto Herbal Remedies Inc. (“THR“), a licenced producer under the Cannabis Act, has received a research licence from Health Canada effective April 11, 2022. The licence allows THR to evaluate the ingredients produced by the proprietary APP technology and product formulations incorporating these ingredients.

“We are pleased to receive this license since we can now evaluate our proprietary extracts and the unique 2.0 product formulations before moving them forward to manufacturing and sale to Canadian consumers.” said Arup Sen, CEO & Director. “We believe it is important to know the sensory characters of the products we market and this license will allow us to further improve upon our beverage and edible product candidates”, he added.

About Sproutly Canada, Inc. 

Sproutly’s core mission is to become the leading supplier to the cannabis beverage and edibles market. Our Toronto based, ACMPR licensed facility was built to cultivate pharmaceutical grade cannabis to supply a technological breakthrough in producing and formulating the first natural, truly water-soluble cannabis solution. Our water-soluble ingredients and our bio-natural oils will deliver revolutionary brands to international markets that are clamouring for well-defined commercial products. Sproutly’s business focus is to execute on partnerships with local and globally established consumer brands to leverage their existing customer bases, further expand brand loyalty, assist with marketing, and support distribution networks to deliver this scientific breakthrough with speed and efficiency worldwide.

For more information on Sproutly, please visit: www.sproutly.ca.

Forward-Looking Statements

Cautionary Note Regarding Forward-Looking Statements: This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws or forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements relate to future events or future performance and reflect the expectations or believes regarding future events of management of Sproutly Canada.  Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or “occur”. This information and these statements, referred to herein as “forward‐looking statements”, are not historical facts, are made as of the date of this news release and include without limitation, statements regarding discussions of future plans, estimates and forecasts and statements as to management’s expectations and intentions with respect to, among other things, the expected launch of the Company’s first line of beverage products. These forward‐looking statements involve numerous risks and uncertainties and actual results might differ materially from results suggested in any forward-looking statements. These assumptions, risks and uncertainties include, among other things, the Company successfully completing the development and production of its first line of beverage and cannabis products and obtaining all applicable regulatory approvals from global jurisdictions including Health Canada. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended, such as the Company’s inability to successfully develop and produce its first line of beverage products or the Company’s inability to obtain any necessary regulatory approvals. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that are incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbor.

SOURCE Stone Ridge Exploration 

For further information: Arup Sen, Chief Executive Officer of Sproutly Canada, Email: investors@sproutly.ca